Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Cleary

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Opioid Management|September 25, 2024
Buprenorphine: The Opioid that Cried 'Partial Agonist'Jeffrey J Bettinger, Jacqueline Cleary
Journal of Opioid Management|September 25, 2024
Emerging Trends in Perioperative Buprenorphine ManagementAmanda Engle, Jacqueline Cleary, Amanda Winans
Medicine Access @ Point of Care|October 7, 2022
Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate riskJeffrey Bettinger, Jacqueline Cleary, Jeffrey Fudin
Journal of Opioid Management|September 14, 2021
Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effectsJeffrey Bettinger, Himayapsill Batista Quevedo, Jacqueline Cleary
Journal of Opioid Management|September 14, 2021
The divided dose approach to perioperative buprenorphine -management in patients with opioid use disorderAmanda L Engle, Amanda R M Winans, Linda Demma, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Opioid Management|September 25, 2024
Buprenorphine: The Opioid that Cried 'Partial Agonist'Jeffrey J Bettinger, Jacqueline Cleary
Journal of Opioid Management|September 25, 2024
Emerging Trends in Perioperative Buprenorphine ManagementAmanda Engle, Jacqueline Cleary, Amanda Winans
Medicine Access @ Point of Care|October 7, 2022
Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate riskJeffrey Bettinger, Jacqueline Cleary, Jeffrey Fudin
Journal of Opioid Management|September 14, 2021
Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effectsJeffrey Bettinger, Himayapsill Batista Quevedo, Jacqueline Cleary
Journal of Opioid Management|September 14, 2021
The divided dose approach to perioperative buprenorphine -management in patients with opioid use disorderAmanda L Engle, Amanda R M Winans, Linda Demma, et al.
Pageof 1